Adjuvant therapy of cytomegalovirus IgM plus ve associated biliary atresia: Prima facie evidence of effect

摘要

Aim of study: CMV-IgM + ve associated biliary atresia (CMV-BA) is a distinct etiological subgroup characterized by older age at presentation and a greater degree of inflammation and hepatic fibrosis, leading to a worse outcome. We report our experience with adjuvant antiviral therapy after Kasai portoenterostomy (KPE).